Valneva SE
PAR:VLA

Watchlist Manager
Valneva SE Logo
Valneva SE
PAR:VLA
Watchlist
Price: 4.328 EUR -1.32%
Market Cap: €744.2m

Profitability Summary

Valneva SE's profitability score is 23/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score
23/100
Profitability
Score

Margins

Earnings Waterfall
Valneva SE

Margins Comparison
Valneva SE Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
FR
Valneva SE
PAR:VLA
753.9m EUR
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
385.5B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.7B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
162.9B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.7B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.1B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Valneva SE Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FR
Valneva SE
PAR:VLA
753.9m EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
385.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.7B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
162.9B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.7B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Valneva SE

Last Value
3-Years Average
FCF Margin
Conversion Rate